Access cutting-edge primary progressive aphasia(ppa) treatment through this clinical trial at a research site in Austin. Study-provided care at no cost to qualified participants.
Quick Self-Assessment
See if you qualify for this Austin location
Preparing your pre-screening questions…
Access primary progressive aphasia(ppa) specialists at no cost
This study follows strict safety protocols and ethical guidelines
All study-related primary progressive aphasia(ppa) treatment provided free
Check if you qualify for this primary progressive aphasia(ppa) clinical trial in Austin, TX
No-Cost Study Care
Local to Austin
Convenient for TX residents
Cutting-Edge Treatment
Access to innovative therapies
Expert Medical Care
Close monitoring by specialists
Possible Compensation*
For time and travel
*Compensation varies by study. Confirm details with coordinator.
The goal of this clinical trial is to learn whether home-based brain stimulation combined with virtual speech-language therapy can improve communication abilities in adults with logopenic variant primary progressive aphasia (lvPPA), a language disorder most often caused by Alzheimer's disease. The main questions the study aims to answer are: * Is combining remotely supervised transcranial direct current stimulation (tDCS) with virtual speech-language therapy feasible and acceptable for people with lvPPA? * Does this combined treatment lead to improvements in communication compared to speech-language therapy with sham (placebo) stimulation? * Do individual brain characteristics help predict who benefits most from this treatment? Researchers will compare participants who receive active tDCS plus virtual speech-language therapy to participants who receive sham (placebo) tDCS plus virtual speech-language therapy to see if active brain stimulation enhances communication outcomes. Participants will: * Complete speech-language therapy sessions delivered by video visit. * Receive either active or sham tDCS that is remotely supervised and completed at home. * Complete language and cognitive testing before and after treatment. * Undergo brain imaging and other assessments to help understand treatment response.
Sponsor: Maya Henry
Yes, this clinical trial (NCT07260253) has an active research site in Austin, TX that is currently enrolling participants.
Clinical trials follow strict safety guidelines and ethical standards. This study has been reviewed and approved, and participants are closely monitored by medical professionals. You can withdraw at any time.
Many clinical trials offer compensation for your time and travel expenses. Specific compensation details will be discussed during the screening process. All study-related medical care is provided at no cost.
Absolutely. Participation is completely voluntary. You have the right to withdraw from the study at any time, for any reason, without penalty.
If you're searching for primary progressive aphasia(ppa) treatment options in Austin, TX, this clinical trial (NCT07260253) may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.
Our Austin research site is actively enrolling participants for this clinical trial. You'll receive care from experienced primary progressive aphasia(ppa) specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.
Looking for more options? Browse all primary progressive aphasia(ppa) clinical trials near you to find additional studies recruiting in your area.
See all ankylosing spondylitis clinical trials recruiting in Austin — not just this study.
Browse Ankylosing Spondylitis Trials in Austin →